On December 23, 2023, the Federal Court of Appeal (FCA) held that it was an abuse of process for Apotex to raise invalidity in defending actions under the Patented Medicines (Notice of.
David Schwartz of Smart & Biggar discusses the importance of diagnostic technologies and why the patent system must find an appropriate balance to encourage innovation in this area